Trial Profile
Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2014
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 17 Jul 2014 New trial record